InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interesting technology including the development of CBD by Injection.
Bincovich also told Proactive about their topical vertical that will focus on pain relief.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE